Sabbin labarai a cikin ciwon daji
Fahimtar Ciwon Sakin Cytokine: Dalilai, Alamu, da Jiyya
Introduction Infections, autoimmune diseases, and immunotherapy are among the many potential causes of cytokine release syndrome (CRS), a complicated immune...
Matsayin ma'aikatan lafiya a cikin nasarar CAR T Cell therapy
Paramedics play a crucial role in the success of CAR T-cell therapy by ensuring seamless patient care throughout the treatment process. They provide vital...
Yaya Neman Farfaganda ke Juya Juyin Babban Maganin Ciwon daji?
A fagen ilimin ciwon daji, bayyanar maganin da aka yi niyya ya canza yanayin yanayin jiyya don ci gaba da cutar kansa. Ba kamar chemotherapy na al'ada ba, ...
Amfani da Immunotherapy don Magance Ciwon daji na Late-Stage
Gabatarwa Immunotherapy ya zama hanya mai ban sha'awa a cikin maganin ciwon daji, musamman don maganin ciwon daji na zamani wanda ke da ...
Tsira da kulawa na dogon lokaci a cikin cututtukan daji masu tasowa
Shiga cikin rikitattun rayuwa da kulawa na dogon lokaci ga mutanen da ke fuskantar cututtukan daji masu tasowa. Gano sabbin ci gaba a cikin haɗin gwiwar kulawa...
FastTCAR-T GC012F ya nuna jimlar amsawar 100% a cikin sabbin cututtukan myeloma da yawa.
Gabatarwa Ko da a cikin marasa lafiya da suka cancanta (TE), jiyya na farko-farko don babban haɗari (HR) sabbin kamuwa da cuta mai yawa myeloma (NDMM) suna da ban tsoro ...
CAR T Kwayoyin jiyya don cutar kanjamau masu alaƙa da B-Cell malignancies
CAR T tantanin halitta don cututtukan ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta sun haɗa da gyaggyarawa kwayoyin halittar T na majiyyaci don bayyana masu karɓar antigen na chimeric (CARs) ...
Kididdigar ciwon daji a Indiya 2024: Abubuwan da suka faru, ƙididdiga da tsinkaya
A cikin 2024, ciwon daji zai kasance babban kalubalen kiwon lafiya a Indiya. Kasar na ganin sabbin kararraki sama da miliyan 1.5 a shekara. Ciwon nono da na baki sun fi...
Indiya ta ayyana kansa a matsayin babban birnin duniya - Rahoton Apollo
Indiya ta ayyana hedkwatar cutar kansa a duniya an ayyana Indiya a matsayin "babban birnin cutar kansa na duniya" a bugu na 4 na asibitocin Apollo'...
Mirvetuximab soravtansine-gynx ya amince da USFDA don FRα tabbatacce, platinum-resistant epithelial ovarian, tube fallopian, ko ciwon daji na peritoneal na farko.
Maris 2024: Hukumar Abinci da Magunguna ta ba da izini ga mirvetuximab soravtansine-gynx (Elahere, ImmunoGen, Inc. [yanzu wani ɓangare na AbbVie]) don zama...
Ponatinib tare da chemotherapy ya sami ƙwaƙƙwaran amincewa ta USFDA don sabon kamuwa da cutar sankarar jini na chromosome na Philadelphia.
Maris 2024: Ponatinib (Iclusig, Takeda Pharmaceuticals USA, Inc.) ya sami amincewa da sauri daga Hukumar Abinci da Magunguna don amfani a hade...
Zanubrutinib ya amince da USFDA don sake dawowa ko lymphoma follicular refractory
Maris 2024: Zanubrutinib (Brukinsa, BeiGene USA, Inc.) a hade tare da obinutuzumab an ba da izinin gaggawa ta Abinci da Magunguna…
Ana buƙatar taimako? Ourungiyarmu a shirye take don taimaka muku.
Muna fatan samun lafiya cikin sauri na masoyinku da na kusa.